Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
16.31
-0.57 (-3.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Amylyx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,803 | 1,327 | 257 | 994 | 2,448 | - | |
| Market Cap Growth | 483.03% | 415.49% | -74.11% | -59.40% | - | - | |
| Enterprise Value | 1,492 | 989 | 26 | 644 | 2,292 | - | |
| Last Close Price | 16.31 | 12.08 | 3.78 | 14.72 | 36.95 | - | |
| PE Ratio | - | - | - | 20.17 | - | - | |
| Forward PE | - | - | - | 16.68 | - | - | |
| PS Ratio | - | - | 2.95 | 2.61 | 110.13 | - | |
| PB Ratio | 5.87 | 4.35 | 1.56 | 2.29 | 7.19 | - | |
| P/TBV Ratio | 5.91 | 4.35 | 1.56 | 2.29 | 7.19 | - | |
| P/FCF Ratio | - | - | - | 93.08 | - | - | |
| P/OCF Ratio | - | - | - | 83.39 | - | - | |
| EV/Sales Ratio | - | - | 0.29 | 1.69 | 103.12 | - | |
| EV/EBITDA Ratio | - | - | - | 16.13 | - | - | |
| EV/EBIT Ratio | - | - | - | 16.59 | - | - | |
| EV/FCF Ratio | - | - | - | 60.27 | - | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | - | |
| Debt / EBITDA Ratio | - | - | - | 0.10 | - | - | |
| Debt / FCF Ratio | - | - | - | 0.40 | - | - | |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.06 | -0.85 | -1.00 | -1.09 | |
| Net Debt / EBITDA Ratio | 2.04 | 2.04 | 0.69 | -9.20 | 1.70 | 1.16 | |
| Net Debt / FCF Ratio | 2.52 | 2.52 | 0.86 | -34.38 | 1.87 | 1.28 | |
| Asset Turnover | - | - | 0.25 | 0.84 | 0.09 | 0.01 | |
| Inventory Turnover | - | - | - | 6.39 | - | - | |
| Quick Ratio | 13.98 | 13.98 | 6.23 | 5.02 | 7.78 | 5.53 | |
| Current Ratio | 14.27 | 14.27 | 6.67 | 5.66 | 8.20 | 6.03 | |
| Return on Equity (ROE) | -61.59% | -61.59% | -100.88% | 12.73% | -92.53% | -188.05% | |
| Return on Assets (ROA) | -36.41% | -36.41% | -44.95% | 5.34% | -50.63% | -86.34% | |
| Return on Invested Capital (ROIC) | - | - | -904.22% | 106.30% | - | - | |
| Return on Capital Employed (ROCE) | -49.50% | -49.50% | -154.70% | 8.90% | -58.40% | -93.70% | |
| Earnings Yield | -8.03% | -10.91% | -117.25% | 4.96% | -8.10% | - | |
| FCF Yield | -6.85% | -9.31% | -79.27% | 1.07% | -7.45% | - | |
| Buyback Yield / Dilution | -38.78% | -38.78% | 2.64% | -19.65% | -788.13% | -8.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.